Bacteria usually forms biofilms to be able to protect themselves from antibiotics and the body’s immune system. The electrical interactions help bacteria communicate with each other. Once the bacteria is on a surface, they are able to signal activity and multiply. They then encase inside a biofilm.
The Vomaris material uses Advanced Microcurrent Technology to generate microcurrents that are designed to replicate the physiologic electric currents that the body emits to reduce the risk of infection and support natural healing.
Dr. Chandan Sen, professor of surgery and director of the comprehensive wound center at The Ohio State University Wexner Medical Center has gathered evidence from the impact of Vomaris’s wireless electroceutical device on disrupting and prevent biofilm in wounds.
To be able to test Vomaris’s device, Sen and his research team turned to pig-based testing since highly pathogenic biofilm-forming bacteria can’t be formed outside of a pre-clinical wound setting.
“The work done by Dr. Sen and his team is robust and exemplary. It demonstrates that Vomaris’s Advanced Microcurrent Technology can present a practical and clinically viable non-pharmacologic alternative to antimicrobial and antibiofilm efficacy in wound care. We are very excited about the role our products can play in addressing the global challenge of biofilm-induced antibiotic resistance,” said Mike Nagel, president and CEO of Vomaris Innovations, in a press release.
[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]